Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

Inclusion Criteria: * Written Informed Consent by patient and/or guardian/parents * Patients with one of the following diagnosis: Growth failure due to growth hormone deficiency (GHD), Turner syndrome, or growth retardation in children with chronic renal disorders * Patients who are willing to inject themselves and answer questionnaires or young patients whose parents/guardian are willing to inject their child and answer questionnaires * Patients on growth hormone therapy for at least 6 weeks before entering the trial Exclusion Criteria: * Pregnancy or breast feeding women * Suspected or known allergy to trial product * Other daily injection therapy (non-growth hormone, e.g insulin-therapy) * Participating in any other trial involving other investigational products within the last 3 months